Elevated sCD22 levels have been detected in the peripheral blood of AD patients, are negatively correlated with CSF Aβ42 levels and Aβ42/Aβ40 ratios, and are positively correlated with phosphorylated tau levels and amyloid burden in the brain [125]. This evidence concerns the gene MAPT and Alzheimer disease.